NAA30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.4415000304524E-09 |
Normal-vs-Stage2 |
7.55210000000783E-05 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.99795735511543E-12 |
Stage1-vs-Stage2 |
3.356600E-01 |
Stage1-vs-Stage3 |
1.66461999999701E-05 |
Stage1-vs-Stage4 |
4.189300E-04 |
Stage2-vs-Stage3 |
1.097410E-01 |
Stage2-vs-Stage4 |
1.441190E-01 |
Stage3-vs-Stage4 |
9.070000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
3.35389999994717E-07 |
Normal-vs-Asian |
1.460060E-02 |
Caucasian-vs-AfricanAmerican |
8.637400E-01 |
Caucasian-vs-Asian |
5.430000E-01 |
AfricanAmerican-vs-Asian |
5.601200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
3.24520410543983E-11 |
Male-vs-Female |
3.228600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.017370E-04 |
Normal-vs-Age(41-60Yrs) |
5.43890044113482E-10 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
1.25599997069514E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.424800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.038800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.836800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.438000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.801800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.622000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.126770E-01 |
Normal-vs-Grade 2 |
1.95860000440362E-08 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
1.62592161956354E-12 |
Grade 1-vs-Grade 2 |
3.392600E-01 |
Grade 1-vs-Grade 3 |
6.620000E-03 |
Grade 1-vs-Grade 4 |
1.477770E-03 |
Grade 2-vs-Grade 3 |
2.008000E-04 |
Grade 2-vs-Grade 4 |
3.54220000000627E-05 |
Grade 3-vs-Grade 4 |
3.768100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.50030004770252E-09 |
Normal-vs-ccB subtype |
1.81044068625624E-12 |
ccA subtype-vs-ccB subtype |
7.229600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.72635297355373E-14 |
Normal-vs-N1 |
2.01416661127496E-12 |
N0-vs-N1 |
7.958500E-04 |
|
|